All In Biotech

Drug Trial Radar · NCT01095640

Study Comparing 0.3% Adapalene Topical Gel to Differin® 0.3% Adapalene Topical Gel

A Multicenter, Double-Blind, Randomized, Vehicle-Controlled, Parallel Group Study Comparing 0.3% Adapalene Topical Gel (Actavis Mid Atlantic LLC) to Differin® (0.3 % Adapalene Topical Gel) (Galderma Laboratories, L.P.) and Both Active Treatments to a Vehicle Control (Actavis Mid Atlantic LLC) in the Treatment of Mild to Moderate Acne Vulgaris

Last checked: Nov 19, 2026Latest source record: Mar 30, 2010 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 1,159 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,159

Actual

Start

Mar 2009

Primary completion

Dec 2009

Study completion Dec 2009

Sponsor

Lead sponsor
Actavis Mid-Atlantic LLCIndustry
Sponsor type
Industry
First posted
Mar 30, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Marketed by Galderma Laboratories, L.P., Differin® (adapalene 0.3% topical gel) is a safe and effective topical therapy used for the treatment of acne vulgaris. Actavis Mid-Atlantic LLC has developed a generic formulation of adapalene 0.3% topical gel and the current study is designed to evaluate the safety and efficacy of this formulation.

Conditions

  • Acne Vulgaris

Interventions

  • adapalene 0.3% topical gelDrug

    once a day, 84 days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Therapeutic EquivalenceTime frame: 12 weeks
  2. SuperiorityTime frame: 12 Weeks
  3. SafetyTime frame: 12 Weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • L.T.M. Medical College & General Hospital

    Mumbai, India

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.